[1]
“Estimation of Remogliflozin Etabonate Active Pharmaceutical Ingredient by Reverse Phase High-Performance Liquid Chromatography Method and Characterization of its Degradation Products by Liquid Chromatography-Mass Spectrometry”,
AJP, vol. 18, no. 01, Mar. 2024, doi:
10.22377/ajp.v18i01.5287.